The U.S. is one of only two countries that allow pharma ads to run ...
Public scrutiny on healthcare costs, particularly drug costs, has been mounting over the past ...
Lately, when people ask me about artificial intelligence and healthcare, I tend to talk ...
A funny thing happens when you talk “convention media.” People focus on how it ...
Have you ever heard about Ohio’s Terminal Distributor of Dangerous Drugs (TDDD) licenses? Before ...
This may come as a shock to many: The amount of time, effort, and ...
The market access landscape for pharmaceutical products has shifted as payers struggle to control ...
When you watch a Texas Hold’em poker tournament on TV, it’s easy to get ...
The pharmaceutical industry’s typical R&D model of developing new chemical entities (NCEs) and creating ...
In this final installment of a three-part series on integrating comprehensive hub services and ...
Every January, tens of thousands of healthcare CEOs, investors, and business development executives descend ...
Improving patients’ health is the cornerstone of treatment strategies. In this patient-centric era, a ...
A true strategic partnership has benefits for both the sponsor and the contract research ...